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BACKGROUND: Standard indicators of quality of care
have been developed in the United States. Limited
information exists about quality of care in countries
with universal health care coverage.
OBJECTIVE: To assess the quality of preventive care
and care for cardiovascular risk factors in a country
with universal health care coverage.
DESIGN AND PARTICIPANTS: Retrospective cohort of a
random sample of 1,002 patients aged 50–80 years
followed for 2 years from all Swiss university primary
care settings.
MAIN MEASURES: We used indicators derived from
RAND’s Quality Assessment Tools. Each indicator was
scored by dividing the number of episodes when
recommended care was delivered by the number of
times patients were eligible for indicators. Aggregate
scores were calculated by taking into account the
number of eligible patients for each indicator.
KEY RESULTS: Overall, patients (44% women) received
69% of recommended preventive care, but rates differed
by indicators. Indicators assessing annual blood pres-
sure and weight measurements (both 95%) were more
likely to be met than indicators assessing smoking
cessation counseling (72%), breast (40%) and colon
cancer screening (35%; all p<0.001 for comparisons
with blood pressure and weight measurements). Eighty-
three percent of patients received the recommended
care for cardiovascular risk factors, including >75% for
hypertension, dyslipidemia and diabetes. However, foot
examination was performed only in 50% of patients
with diabetes. Prevention indicators were more likely to
be met in men (72.2% vs 65.3% in women, p<0.001)
and patients <65 years (70.1% vs 68.0% in those
≥65 years, p=0.047).
CONCLUSIONS: Using standardized tools, these adults
received 69% of recommended preventive care and 83%
of care for cardiovascular risk factors in Switzerland, a
country with universal coverage. Prevention indicator
rates were lower for women and the elderly, and for
cancer screening. Our study helps pave the way for
targeted quality improvement initiatives and broader
assessment of health care in Continental Europe.
KEY WORDS: quality of health care; insurance coverage; primary health
care; primary prevention.
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BACKGROUND
Standard indicators of the quality of preventive and chronic
disease care have been developed and evaluated in the United
States.1,2 Using RAND’s Quality Assessment (QA) Tools, a
quality assessment system that spans over 30 conditions and
prevention, McGlynn et al. found that US adults received 55%
of recommended health care services in 12 metropolitan
areas.1 In the UK, a systematic performance monitoring was
introduced in 2004 coupled with financial incentives,3 the
Quality and Outcomes Framework (QOF).
We have limited information about the quality of preventive
care in Continental Europe. Most previous studies on the
quality of preventive care in Europe have assessed only a few
indicators of quality for many conditions,4 or one condition at
a time, such as hypertension5,6 or diabetes.7,8 Thus, we have
limited data on the quality of preventive care given to adults in
Continental Europe, particularly using standardized tools. In
Switzerland, quality of care has been assessed for only a few
specific conditions.9–11
The Swiss and US health care systems differ on at least two
points. In Switzerland, all patients have universal health care
coverage, including adults with low income who receive social
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aid to cover health care costs, regardless of their age or
whether they work. Patients are free to choose their primary
care physician (PCP). Second, systematic performance moni-
toring and annual report cards on quality of care, such as the
US Healthcare Effectiveness Data and Information Set
(HEDIS),12 and financial incentives to improve quality are not
implemented in Switzerland. While this practice is not univer-
sal in the US and in Europe, limited data exist on the quality of
care in a country without such quality improvement programs.
We therefore sought to assess the quality of care in Switzer-
land, using indicators adapted from RAND’s QA Tools.1 We
focused our study on primary and secondary prevention, and
thus assessed the delivery of preventive care and chronic care
for cardiovascular risk factors (CVRFs) to 1,002 randomly
selected adults from all Swiss university primary care settings.
METHODS
Study Design and Patients
In a retrospective cohort study, we abstracted medical charts
from a random sample of patients followed by PCPs in all Swiss
university primary care settings (Basel, Geneva, Lausanne and
Zürich). This study was approved by the Institutional Review
Board at each site. Most of the care was provided by residents
in general internal medicine at the end of their postgraduate
training (n=902, 90%), supervised by university attendings,
while 100 patients (10%) were followed by university attend-
ings. The random sample was drawn from electronic adminis-
trative data of all patients aged 50 to 80 years followed in
2005–2006. We limited our sample to this age group to have a
high enough prevalence of examined indicators (e.g., CVRFs,
eligibility for cancer screening or influenza immunization). A
similar sample size was used in previous studies on quality of
care based on chart abstraction.13,14
Among the 1,889 patients in the starting random sample
identified from electronic administrative data, 54 charts could
not be found, most likely because the patients left the clinical
setting for another practice. Compared to included patients,
these 54 patients had a similar age (63.5 years vs 64.0, p=0.65)
and proportion of women (35% vs 44%, p=0.22). Among the
1,835 reviewed medical charts, 591 had <1 year follow-up in the
primary care clinic during the review period, 125 patients had no
outpatient visit to a PCP during the review period (emergency
visits or nurse appointments only), and 117 were followed in a
specialized clinic only. We did not include patients who were
followed in the clinical setting for <1 year to have adequate time
and information to assess provided preventive care. The final
sample included 1,002 abstracted medical charts.
Quality Indicators
We selected 37 quality indicators from RAND’s QA Tools1,2
concerning preventive care and the care of CVRFs. This system
was previously developed in the US to evaluate the quality of
care delivered to adults.15 Briefly, RAND staff physicians
reviewed established national guidelines and the medical
literature for each condition. Chosen indicators focused on
processes of care, because they represent the activities that
clinicians control most directly.1 Multispecialty expert panels
chose the final RAND indicators using the RAND-UCLA
modified Delphi method.16
As our aim was to examine care related to primary and
secondary prevention, we selected 37 indicators: 14 for preven-
tive care (physical examination: 3; alcohol: 2; smoking cessation:
5; cancer screening: 2; influenza immunization: 2), 19 for chronic
care of three major CVRFs (hypertension: 4; dyslipidemia: 2;
diabetes: 13) and 4 for chronic care for cardiovascular disease
(Tables 2 and 3, unabridged indicators in Appendix Table 1,
available online). The definitions of hypertension, dyslipidemia
and diabetes were adapted from a previous study17 (Appendix
Table 2, available online). We did not include preventive care
indicators that were not applicable to our local guidelines or PCP
settings (e.g., pregnancy follow-up is very rarely performed by
PCPs in Switzerland) or that involved information usually not
collected in charts in Switzerland or adults aged 50–80 years, or
indicators for conditions of low prevalence in our sample (e.g.,
asthma). Excluded quality indicators are listed at the bottom of
Appendix Table 1 (available online). We included indicators on
coronary artery disease, as it is the most common cause of death
in Switzerland.18
Chart Abstraction
A chart review was performed for data abstraction, similar to
previous studies with direct abstraction from medical
charts.1,13,14,19 A data abstraction form was created to assess
the 37 selected indicators for chronic and preventive care
derived from RAND’s QA Tools1 (Appendix Table 2, available
online). Other abstracted covariates (demographics, chronic
comorbid conditions) were based on a chart abstraction form
from the TRIAD study19 (Translating Research into Action for
Diabetes), a study about the quality of diabetes care in the US.
Nine medical students were centrally trained at one site
(Lausanne) for data abstraction from medical charts in each
Swiss university primary care setting and then entered the
data with EpiData software (version 3.1, EpiData Association,
Denmark).
To assess inter-rater reliability, we repeated the chart
abstraction on a random sample of patients (n=45, to detect
a statistically significant kappa20) at one site (Lausanne). Inter-
rater reliability using the kappa statistic ranged from 0.66 to
1.0 for the main quality indicators, consistent with a previous
study using a similar method.19 The inter-rater reliability was
lower (0.35 to 0.57) for some indicators that were prone to
interpretation (e.g., lifestyle modifications for hypertension) or
those that required a specific recommended frequency over the
2 years (e.g., eye exam annually, foot exam and HbA1c twice a
year for diabetics). As a sensitivity analysis, we tested whether
the exclusion of indicators with lower inter-rater reliability
(kappa <0.6) or indicators that are gender-specific (breast
cancer screening) changed the global aggregate scores.
Statistical Analysis
For each selected indicator of preventive care and chronic
care for CVRFs, we calculated the percentage of provided
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recommended care by dividing all episodes in which
recommended care was delivered by the number of times
patients were eligible for indicators (overall percentage
method21). When care was refused by eligible patients, it
was counted as provided care to measure physician-initiat-
ed care. The results were presented as percentages with
95% binomial exact confidence intervals (CI). To summarize
the selected indicators, we calculated aggregate scores of
quality of care among the different categories of prevention
(physical examination, counseling, screening and immuni-
zation) and a global aggregate score for preventive care. All
these aggregate scores were calculated by taking into
account the number of eligible patients for each selected
indicator. The same method of calculation was used to
obtain the aggregate scores of chronic care for hyperten-
sion, dyslipidemia and diabetes, and a global aggregate
score for chronic care for CVRFs, summarizing care for
these three conditions.
We used generalized estimating equation (GEE) binomial
models to compare differences in rates of recommended
preventive care and to assess the association between
demographic characteristics (age, gender) and the propor-
tion of provided care. GEE models were used to account for
correlation of multiple measurements for the same patient
and for different numbers of eligible patients for each
recommended preventive care. To account for clustering by
the four sites, we treated each primary care center as a fixed
effect. For all statistical analyses, Stata software (version
10.1, Stata Corp., College Station, TX) was used.
RESULTS
Characteristics of the Patients
The mean age of our sample was 63.5 years with 44%
women and 51% married patients (Table 1). Thirty-eight
percent of patients were retired and 29% employed. During
the 2-year review period, the median number of outpatient
visits was 10 (range 2–63, SD 6.5). The prevalence of CVRFs
was 75% for hypertension, 62% for dyslipidemia and 29%
for diabetes. Twenty-three percent of the participants were
current smokers, 36% had a prior cardiovascular disease,
22% a psychiatric disorder and 20% a chronic pulmonary
disease.
Analysis of Delivered Care
Tables 2 and 3 show the selected indicators, the aggregate
scores, the number of eligible patients for each indicator and
the number of patients who were provided such care. Patients
received 69% of recommended preventive care, but this result
differed by specific indicators. Indicators assessing annual
blood pressure and weight measurements (both 95%) were
more likely to be met than indicators assessing alcohol
consumption counseling (77%), smoking cessation counseling
(72%), breast cancer (40%) and colon cancer screening (35%;
all p<0.001 for comparisons with blood pressure and weight
measurements). The level of performance according to the
particular aggregate score ranged from 88% for physical
examination to 33% for influenza immunization.
Eighty-three percent of patients received the recom-
mended care for CVRFs, including >75% for hypertension,
dyslipidemia and diabetes. However, glycosylated hemoglo-
bin was measured at least twice a year in 72% of diabetics,
and foot examination was performed twice a year in 50%.
Daily aspirin was recommended to 95% of patients with
coronary artery disease (n=152). Among the 60 patients
with previous myocardial infarction, beta-blockers were
prescribed to 82% of patients. Eighty-nine percent of
patients received antiplatelet therapy after stroke or tran-
sient ischemic attack (n=74) and 89% of patients with heart
Table 1. Patients' Characteristics: Random Sample of 1,002 Adults
Aged 50–80 Years in All Swiss University Primary Care Settings
Characteristic
Age, mean (SD) 63.5 (8.3)
Range, minimum – maximum 50–80
Women, no. (%) 445 (44.4)
Civil status, no. (%)
Married 506 (51.0)
Divorced, separated 233 (23.5)
Single 151 (15.2)
Widow/-er 103 (10.4)
Occupation, no. (%)
Retired 372 (37.9)
Employed 285 (29.0)
At home or in education 115 (11.7)
Social aid 109 (11.1)
Unemployed or other 101 (10.3)
Number of outpatient visits over 2 years
Median (interquartile range) 10 (7–15)
Range, minimum – maximum 2–63
Cardiovascular risk factors
Hypertension*, no. (%) 753 (75.2)
Dyslipidemia*, no. (%) 622 (62.1)
Diabetes*, no. (%) 292 (29.1)
Family history of early CHD†, no. (%) 99 (9.9)
Smoking status at baseline‡, no. (%)
Former smokers 177 (17.7)
Current smokers 230 (23.0)
Comorbid conditions
Cardiovascular disease§, no. (%) 364 (36.3)
Chronic pulmonary disease‖, no. (%) 201 (20.1)
Non-metastatic solid cancer¶, no. (%) 133 (13.3)
Metastatic solid cancer, no. (%) 16 (1.6)
Hematological cancer, no. (%) 10 (1.0)
Dementia, no. (%) 24 (2.4)
Psychiatric disorders#, no. (%) 287 (28.6)
*For criteria of dyslipidemia, hypertension and diabetes, see Appendix
Table 2 (available online)
†Early coronary heart disease (CHD) defined as a CHD event in male
relatives <55 years or in female relatives <65 years
‡Smoking status defined as: former smoker=stopped smoking≥6 months
before baseline; current smoker=smoking at baseline or stopped
<6 months before baseline
§History of transient ischemic attack, cerebral vascular accident, coro-
nary artery disease, angina, myocardial infarction, congestive heart
failure or peripheral vascular disease
‖Classification based on Charlson index37: chronic obstructive pulmo-
nary disease (COPD), asthma, sleep apnea syndrome, sarcoidosis,
pulmonary hypertension, bronchiectases, interstitial pulmonary disease
or global respiratory insufficiency
¶Includes prostate, colorectal, breast, lung, kidney, urothelial, gynecolog-
ical and other types of cancer in the last 5 years
#Classification based on Charlson index37: depression, psychotic disor-
der and bipolar disorder
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failure (n=47) an angiotensin-converting enzyme inhibitor or
an angiotensin-receptor blocker.
In multivariate analyses adjusted for age, gender and
center as a fixed effect, prevention indicators were more likely
to be met in men (72.2% vs 65.3% in women, p<0.001) and
patients <65 years (70.1% vs 68.0% in those ≥65 years, p=
0.047, Fig. 1). Removing the only gender-specific indicator
(i.e., breast cancer screening) from this analysis yielded
similar results.
Adherence rates to chronic care for CVRFs did not differ
according to age and gender (both p>0.10). Sensitivity
analyses excluding two indicators for hypertension and
three indicators for diabetes, with lower inter-rater reliability
(see Methods), yielded a higher aggregate score for chronic
care of CVRFs (93% vs 83%). Results for aggregate scores
were similar between patients followed by residents and
university attendings.
Comparison with Other Settings
The rates of recommended preventive care and chronic care for
CVRFs in this study were compared with similar indicators from
US HEDIS 2006 results,12 when available (Table 4). Overall,
quality of care did not differ between the two settings for CVRFs
and smoking cessation. The major differences were for influenza
immunization and breast and colorectal cancer screening, which
were performed farmore frequently in theUS than inSwitzerland.
DISCUSSION
Using standardized indicators developed in the US,1 we found
that adults in university primary care settings received 69% of
recommended preventive care and 83% of chronic care for
CVRFs in Switzerland, a country with universal health care
coverage but no systematic performance monitoring. Women
and the elderly had lower receipt of recommended preventive
care, and rates of cancer screening were low (<40%).
In the US, several studies have been conducted about the
quality of care. McGlynn et al.1 found that US adults
received about 55% of recommended care. The comparison
of our results with the McGlynn study was limited because
that study reported data from 1998–2000. The comparison
with US HEDIS 2006 results12 yielded a mixed picture
(Table 4). Interestingly, although the methods of measure-
ment and the studied populations differed somewhat be-
tween HEDIS12 and our study, quality of care in Swiss
university primary care settings was comparable to that in
the US, except for lower rates of cancer screening and
influenza immunization in Switzerland, even though there
is no systematic performance monitoring, nor mandatory
Table 2. Recommended Preventive Care
Indicator Preventive care Eligible patients no. Care provided* no. Care provided
% (95% CI)
Physical examination
1 Annual blood pressure measurement 1,002 952 95.0 (93.5–96.3)
2 Weight measurement 1,002 952 95.0 (93.5–96.3)
3 Height measurement 1,002 753 75.1 (72.4–77.8)
Aggregate score for physical examination 88.4 (87.2–89.5)
Alcohol consumption counseling
4 Asked about drinking problem 1,002 671 67.0 (64.0–69.9)
5 Advice to decrease drinking for at-risk or binge drinkers† 132 102 77.3 (69.2–84.1)
Aggregate score for alcohol consumption counseling 68.2 (65.4–70.9)
Smoking cessation counseling
6 Smoking status documented 1,002 789 78.7 (76.1–81.2)
7 Annual advice to quit smoking 230 165 71.7 (65.4–77.5)
8 Counseling offered to smokers attempting to quit 77 52 67.5 (55.9–77.8)
9 Pharmacotherapy offered to smokers attempting to quit if
>10 cigarettes/day
77 37 48.1 (36.5–59.7)
10 Abstinence documented 4 weeks after smoking cessation counseling 52 24 46.2 (32.2–60.5)
Aggregate score for smoking cessation counseling 74.2 (71.9–76.4)
Cancer screening
11 Screening for colon cancer (aged 50–80)‡ 984 345 35.1 (32.1–38.1)
12 Screening for breast cancer (aged 50–70)‡ 310 125 40.3 (34.8–46.0)
Aggregate score for cancer screening 36.3 (33.7–39.0)
Influenza immunization
13 Annual influenza vaccine for patients ≥65 years 426 150 35.2 (30.7–40.0)
14 Annual influenza vaccine for immunocompromised patients
<65 years§
276 81 29.3 (24.0–35.1)
Aggregate score for influenza immunization 32.9 (29.4–36.5)
Global aggregate score for Preventive Care 68.6 (67.6–69.7)
*When care was refused by eligible patients, it was counted as provided care to measure physician-initiated health care. When care was provided less
frequently than specified (i.e., once a year instead of twice a year or only once instead of annually), it was counted as unprovided care to measure
physician adherence to recommendations
†At-risk drinking was defined as >14 drinks per week for men <65 years or >7 drinks per week for others. Binge drinking was defined as >4 drinks per
occasion for men <65 years or >3 drinks for others
‡Patients were excluded from screening because of a prior diagnosis of colon cancer (n=18) or breast cancer (n=17)
§Indications for influenza immunization for <65 years: living in a nursing home, chronic cardiovascular disease, chronic obstructive pulmonary disease,
renal failure, diabetes, immunosuppression, hemoglobinopathy
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annual report cards on quality of care in Switzerland. Our study
was not designed to assess the reasons for unprovided recom-
mended care, but hypotheses are the lack of a national campaign
for cancer screening, the limited information in the media about
health issues in Switzerland, compared to the US, and the lack of
systematic performancemonitoring with regular feedback (which
might improve PCPperformance22). AnolderSwiss study23 found
similarly low rates of influenza immunization (41% if age
<65 years with chronic illness and 51% if >65 years), suggesting
a lower acceptance of influenza immunization24 than in the US.
Another study using RAND’s QATools showed that quality of care
in the US Department of Veterans Affairs (VA) was higher than
that in the community.14 Much of the difference was attributable
to VA scoring higher in conditions subject to VA performance
monitoring. The high overall level of care we foundmay be related
to universal coverage or to the specific setting. Indeed, quality of
care might have been lower if we had included community-based
PCP offices outside of university primary care settings, like in the
US14 or UK25,26 studies.
To our knowledge, this is the first study to document the
quality of a broad range of primary and secondary preven-
tive care indicators in Continental Europe. In the UK, the
systematic performance monitoring known as QOF3 was
introduced in 2004. Current published data were limited to
patients with cardiovascular diseases26 or diabetes,25 which
may not be applicable to the general population. In over a
million patients with diabetes followed in 147 clinics,
Calvert et al.25 found higher rates of HbA1c testing (89.3%
vs 71.9% in our study), annual eye examination (75.0% vs
55.8%) or screening for nephropathy (74.1% vs 65.1%), but
a lower rate of cholesterol testing (89.7% vs 97.6%). Other
quality indicators of the prevention and management of cardio-
vascular diseases in primary care have been developed across
nine European countries,4 but no data using this new set of
Table 3. Recommended Chronic Care for Cardiovascular Risk Factors
Indicator Chronic care for cardiovascular risk factors Eligible patients no. Care provided* no. Care provided
% (95% CI)
Diabetes
15 Diabetes documented for patients <75 years 249 241 96.8 (93.8–98.6)
16 Glycosylated hemoglobin (HbA1c) twice a year† 292 210 71.9 (66.4–77.0)
17 Annual eye and visual exam† 292 163 55.8 (49.9–61.6)
18 Cholesterol tests documented 292 285 97.6 (95.1–99.0)
19 Annual proteinuria 292 190 65.1 (59.3–70.5)
20 Foot examination twice a year† 292 147 50.3 (44.5–56.2)
21 Blood pressure documented 292 291 99.7 (98.1–100.0)
22 Follow-up visits twice a year 292 259 88.7 (84.5–92.1)
23 Glucose monitoring for diabetics taking insulin 103 101 98.1 (93.2–99.8)
24 Dietary and exercise counseling for newly
diagnosed diabetics
58 57 98.3 (90.8–100.0)
25 Oral hypoglycemics for type 2 diabetics who have
failed dietary therapy (HbA1c ≥7% after 6 months)
75 67 89.3 (80.1–95.3)
26 Insulin offered to type 2 diabetics who have failed
oral hypoglycemics (HbA1c ≥7% with two oral drugs
after 6 months)
75 54 72.0 (60.4–81.8)
27 Angiotensin-converting enzyme inhibitor or angiotensin
receptor blocker‡ offered within 3 months after noting
proteinuria or microalbuminuria§
96 85 88.5 (80.4–94.1)
Aggregate score for diabetes 79.6 (78.1–81.1)
Hypertension
28 Diagnosis of hypertension when 3 separate visits
with blood pressure ≥140/90 mmHg
639 614 96.1 (94.3–97.5)
29 Lifestyle modification for hypertension† 753 485 64.4 (60.9–67.8)
30 Annual visit for hypertensive patients 753 751 99.7 (99.0–100.0)
31 Pharmacotherapy or lifestyle modification for uncontrolled
hypertension (≥140/90 mmHg over 6 months)†
502 389 77.5 (73.6–81.1)
Aggregate score for hypertension 84.6 (83.2–85.9)
Dyslipidemia
32 Two cholesterol tests before start of therapy 174 154 88.5 (82.8–92.8)
33 Cholesterol tests if heart disease and no pharmacological therapy 138 134 97.1 (92.7–99.2)
Aggregate score for dyslipidemia 92.3 (88.8–95.0)
Global aggregate score for care for cardiovascular risk factors 82.6 (81.6–83.6)
Chronic care for cardiovascular diseases‖
34 Aspirin for coronary artery disease 152 144 94.7 (89.9–97.7)
35 Beta-blockers after acute myocardial infarction 60 49 81.7 (69.6–90.5)
36 Antiplatelet therapy after stroke or transient ischemic attack 74 66 89.2 (79.8–95.2)
37 Angiotensin-converting enzyme inhibitor or
angiotensin-receptor blocker‡ for heart failure
with ejection fraction <40%
47 42 89.4 (76.9–96.5)
*When care was refused by eligible patients, it was counted as provided care to measure physician-initiated health care. When care was provided less
frequently than specified (i.e., once a year instead of twice a year, or only once instead of annually), it was counted as unprovided care to measure
physician adherence to recommendations
†These indicators with lower inter-rater reliability (kappa <0.6) were excluded in a sensitivity analysis
‡Angiotensin-receptor blocker was added according to Joint National Committee 7th guidelines38
§Microalbuminuria was added according to American Diabetes Association guidelines39
‖When care was contraindicated, the patient was not counted as eligible, thus reducing the denominator
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indicators have been published yet. For Switzerland, no study
has been published on the overall quality of preventive care, but
only on specific conditions.9–11
Men received more recommended care than women. The
gender differences in quality of care are consistent with studies
on hypertension,27 dyslipidemia,28 diabetes care29,30 or therapy
introduced after cardiovascular events.31–33 More attention
should be placed on preventive care for women in Switzerland.
Patients <65 years also received more recommended care
than the elderly, although the 2.1% difference was borderline
statistically significant and may not be clinically meaningful.
The lower rate of recommended care among older adults might
be related to the higher number of indicators for which older
adults became eligible or to lower attention to preventive care.
Our findings of lower preventive care in the elderly are similar to
those of a previous US study,2 but need to be confirmed by
further research.
The higher level of quality of care for CVRFs compared to
preventive care might be explained by the ease of ordering
laboratory tests or prescribing new medications compared to
counseling on lifestyle modifications or cancer screening.
Counseling might also have been subject to more underreport
than laboratory tests in medical charts.
Our study has several limitations. Our data were only
abstracted from medical charts with potential underreporting.
A previous study compared process-based quality scores using
standardized patients, clinical vignettes and abstraction of
medical charts, and found that measurement of quality of care
using abstraction of medical charts was about 5% lower than
using clinical vignettes and 10% lower than using standardized
patients.34 As influenza immunization can be done directly by
nurses in Switzerland, we validated the influenza immunization
indicators with an external administrative register at one site
(Lausanne) and found that 8% of patients had actually been
immunized, although this information was not reported in the
medical chart, a similar rate as in the previous report described
above.34 Another limitation was that some indicators had a
lower inter-rater reliability (see Methods). Sensitivity analyses
excluding these indicators yielded a higher aggregate score for
chronic care of CVRFs (93% vs 83%), which might be explained
by the lower rates of provided care for these indicators with a
lower kappa statistic. A third limitation was that our data were
only abstracted in university primary care settings, where almost
all patients received their care from residents. Aggregate
scores were similar for patients followed by residents and
university attendings, but the proportion of patients fol-
lowed by university attendings (10%) was small for such
comparisons. A previous study found a higher adherence to
diabetes care guidelines by internal medicine residents
compared to faculty members,35 whereas another found
similar rates of performance for preventive care between
residents and attendings.36 One study among Swiss com-
munity-based PCPs found similar results for diabetes care11
(as measured by face-to-face interviews of PCPs) compared
to our study. However, we did not find studies directly
comparing performance between community-based PCPs
and university-based residents. Therefore, our data may
not be generalizable to community-based PCPs. Additionally,
our study included slightly fewer women in university
primary care settings than the natural gender ratio of the
Swiss general population (44.4% vs 50.8% of women,
respectively), which might be related to the fact that many
healthy Swiss women are followed only by gynecologists.
In summary, using indicators fromRAND’s QATools, adults in
university primary care settings received 69% of recommended
preventive care and 83% of chronic care for CVRFs in Switzer-
land, a country without systematic performance monitoring but
universal insurance coverage. Women and the elderly had lower
receipt of recommended preventive care services, and cancer
screening rates were low. Our findings suggest that, like in the
US, there still is substantial room for improvement in preventive
care delivered to Swiss adults, in particular for cancer screening
Table 4. Comparison with Healthcare Effectiveness Data and
Information Set (HEDIS)*
Indicator Switzerland
2005–2006
United
States*
2006
Smoking cessation counseling
7 Annual advice to quit 71.7 73.8
8 Pharmacotherapy offered to
smokers
48.1 43.9
Diabetes
16 HbA1c screening† 71.9 87.5
17 Annual eye exam screening 55.8 54.7
18 LDL-cholesterol screening 97.6 83.4
19 Monitoring nephropathy‡ 65.1 79.7
Cardiovascular disease
35 Beta blockers a year after heart
attack
81.7 72.5
Cancer screening
11 Colorectal cancer 35.2 54.5
12 Breast cancer§ 39.7 72.0
Influenza immunization
13 All patients >65 years‖ 35.2 70.3
14 Potentially immunocompromised
<65years
29.3 45.6
*Selection of similar indicators on 2006 data from HEDIS,12 when
available
†HbA1c screening twice a year in Switzerland, but once a year in the US
‡Recommended screening for proteinuria in Switzerland, medical atten-
tion for kidney disease in the US
§HEDIS US 2005 rates were reported here as recommended screening
age (50–70 years) was the same as in Switzerland, instead of 40–
70 years (since 2006 in the US)
‖HEDIS US 2005 rates were reported here because such Medicare data
were not available in 2006
Figure 1. Preventive care according to gender and age.
Legend: Preventive care according to gender (white columns,
p value adjusted for age and center as a fixed effect) and age
(grey columns, p value adjusted for gender and center as a
fixed effect).
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and influenza immunization. Our study may allow better target-
ing of future quality initiatives in specific areas and strengthening
the case for broader performance review of quality of care across
Continental Europe.
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